Beyond Tumor Necrosis Factor Inhibition: The Expanding Pipeline of Biologic Therapies for Inflammatory Diseases and Their Associated Infectious Sequelae
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond Tumor Necrosis Factor Inhibition: The Expanding Pipeline of Biologic Therapies for Inflammatory Diseases and Their Associated Infectious Sequelae
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 58, Issue 11, Pages 1587-1598
Publisher
Oxford University Press (OUP)
Online
2014-03-01
DOI
10.1093/cid/ciu104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
- (2013) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
- (2013) Joel Kremer et al. ANNALS OF INTERNAL MEDICINE
- The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
- (2013) H.-Y. Chiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Incidence and Risk Factors of Legionella pneumophila Pneumonia During Anti-Tumor Necrosis Factor Therapy
- (2013) Fanny Lanternier et al. CHEST
- Listeriosis in patients receiving biologic therapies
- (2013) M. Bodro et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster
- (2013) Kevin L. Winthrop et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy
- (2013) Kevin L. Winthrop et al. Nature Reviews Rheumatology
- Subcutaneous abatacept for the treatment of rheumatoid arthritis
- (2013) Michael Schiff RHEUMATOLOGY
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2012) James B Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
- (2012) Sanne A A van Dartel et al. ANNALS OF THE RHEUMATIC DISEASES
- You can't always get what you want, but if you try sometimes (with two tests—TST and IGRA—for tuberculosis) you get what you need: Figure 1
- (2012) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycobacterial diseases and antitumour necrosis factor therapy in USA
- (2012) KL Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
- (2012) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
- (2012) Carla Casulo et al. Clinical Lymphoma Myeloma & Leukemia
- Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases
- (2012) Jie Zhang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of rheumatic disease with comorbid HBV or HCV infection
- (2012) Dimitrios Vassilopoulos et al. Nature Reviews Rheumatology
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?
- (2012) Sengwee Toh et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
- (2012) Claire Andréjak et al. THORAX
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs
- (2012) Sara Taroumian et al. ARTHRITIS CARE & RESEARCH
- Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
- (2012) Teresa A Simon et al. ARTHRITIS RESEARCH & THERAPY
- The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
- (2011) J. R. Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Let the fog be lifted: screening for hepatitis B virus before biological therapy
- (2011) K. L. Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
- (2011) K. Au et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
- (2011) A. Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
- (2011) T. Koike et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials
- (2011) Andrew E. Thompson et al. ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe
- (2011) P. Zanger et al. CLINICAL MICROBIOLOGY AND INFECTION
- Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
- (2011) Carlos G. Grijalva et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk
- (2011) Edi Kaminska et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Risk of Herpes Zoster in Patients Receiving Anti-TNF-α in the Prospective French RATIO Registry
- (2011) Gaelle Serac et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials
- (2011) Mark Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials
- (2011) Kenneth B. Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
- (2011) Daisuke Hoshi et al. Modern Rheumatology
- Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review
- (2011) A. M. G. Brunasso et al. RHEUMATOLOGY
- Incidence and risk factors for Progressive Multifocal Leukoencephalopathy among patients with selected rheumatic diseases
- (2011) A. Bharat et al. ARTHRITIS CARE & RESEARCH
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
- (2011) William G Dixon et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
- (2010) A. M. Evens et al. ANNALS OF ONCOLOGY
- Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy
- (2010) K. L. Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2010) S. van Assen et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
- (2010) D. Salmon-Ceron et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment
- (2010) B. Denis et al. CLINICAL MICROBIOLOGY AND INFECTION
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
- (2010) I. Solovic et al. EUROPEAN RESPIRATORY JOURNAL
- Infectious Complications Associated with Immunomodulating Biologic Agents
- (2010) Sophia Koo et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Does rituximab aggravate pre-existing hypogammaglobulinaemia?
- (2010) L. Diwakar et al. JOURNAL OF CLINICAL PATHOLOGY
- Observational Studies of Infections in Rheumatoid Arthritis: A Metaanalysis of Tumor Necrosis Factor Antagonists
- (2010) S. BERNATSKY et al. JOURNAL OF RHEUMATOLOGY
- Tumor necrosis factor blockade and the risk of viral infection
- (2010) Seo Young Kim et al. Nature Reviews Rheumatology
- The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy
- (2010) Kevin L. Winthrop et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Abatacept treatment for rheumatoid arthritis
- (2010) M. Schiff RHEUMATOLOGY
- Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
- (2010) L. Campbell et al. RHEUMATOLOGY
- The delivery of evidence-based preventive care for older Americans with arthritis
- (2010) Jeffrey R Curtis et al. ARTHRITIS RESEARCH & THERAPY
- Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
- (2009) M. J. SHALE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials
- (2009) A. Fouque-Aubert et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
- (2009) J D Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Herpes Zoster Risk Factors in a National Cohort of Veterans with Rheumatoid Arthritis
- (2009) Jay R. McDonald et al. CLINICAL INFECTIOUS DISEASES
- Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy
- (2009) Chadi A. Hage et al. CLINICAL INFECTIOUS DISEASES
- Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy
- (2009) Jeannina A. Smith et al. DRUGS
- Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis
- (2009) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed
- (2009) Elizabeth A. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-TNF immunotherapy reduces CD8+ T cell–mediated antimicrobial activity against Mycobacterium tuberculosis in humans
- (2009) Heiko Bruns et al. JOURNAL OF CLINICAL INVESTIGATION
- Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy
- (2009) Sotirios Tsiodras et al. MAYO CLINIC PROCEEDINGS
- Preventing and treating biologic-associated opportunistic infections
- (2009) Kevin L. Winthrop et al. Nature Reviews Rheumatology
- The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
- (2009) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- Biologics : Target - specific treatment of systemic and cutaneous autoimmune diseases
- (2009) SibaP Raychaudhuri et al. INDIAN JOURNAL OF DERMATOLOGY
- Tocilizumab: The first interleukin-6-receptor inhibitor
- (2008) Anthony Sebba AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycobacterial and Other Serious Infections in Patients Receiving Anti–Tumor Necrosis Factor and Other Newly Approved Biologic Therapies: Case Finding through the Emerging Infections Network
- (2008) Kevin L. Winthrop et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search